- Home
- LU vs STAA Comparison
LU vs STAA Comparison
Compare LU & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LU | STAA |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | LU | STAA |
|---|---|---|
| Price | $1.24 | $24.02 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $2.00 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 1.0M | 845.8K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | N/A | $30.82 |
| Revenue Next Year | $22.52 | $8.41 |
| P/E Ratio | ★ N/A | $90.27 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.19 | $15.59 |
| 52 Week High | $4.57 | $35.87 |
Technical Indicators
Market Signals| Indicator | LU | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 37.24 | 50.53 |
| Support Level | $1.20 | $23.27 |
| Resistance Level | $1.45 | $24.26 |
| Average True Range (ATR) | 0.06 | 0.90 |
| MACD | -0.02 | 0.15 |
| Stochastic Oscillator | 12.86 | 57.92 |
Price Performance
Historical ComparisonAbout LU Lufax Holding Ltd each representing two (2)
Lufax Holding Ltd is an investment holding company, together with its consolidated subsidiaries, engaged in core retail credit and enablement business to both borrowers and institutions in the People's Republic of China. The group's segments are Lending-related business, which provides Retail credit and enablement, consumer finance loans, and Digital banking business, including Retail banking and SME banking.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.